You signed in with another tab or window. Reload to refresh your session.You signed out in another tab or window. Reload to refresh your session.You switched accounts on another tab or window. Reload to refresh your session.Dismiss alert
Copy file name to clipboardExpand all lines: _pages/publications.md
+9-8Lines changed: 9 additions & 8 deletions
Display the source diff
Display the rich diff
Original file line number
Diff line number
Diff line change
@@ -12,6 +12,7 @@ Some of my work has been featured in the media, see [here](/media).
12
12
13
13
## Selected Publications
14
14
15
+
* M. Dawood, B. Heavner, M.M. Wheeler, R.A. Ungar, J. LoTempio, **_L. Wiel_**, _et al._**GREGoR: Accelerating Genomics for Rare Diseases.**[_Nature, November 2025_](https://doi.org/10.1038/s41586-025-09613-8)
15
16
***_L. Wiel_**\*, J.E Hampstead\*, _et al._**_de novo_ mutation hotspots in homologous protein domains identify function-altering mutations in neurodevelopmental disorders.**[_The American Journal of Human Genetics, January 2023_](https://doi.org/10.1016/j.ajhg.2022.12.001)
16
17
* J. Kaplanis\*, K.E. Samocha\*, _**L. Wiel**_\*, Z. Zhang*, _et al._**Evidence for 28 genetic disorders discovered by combining healthcare and research data.**[_Nature, Oct 2020_](https://doi.org/10.1038/s41586-020-2832-5)
17
18
***_L. Wiel_**, _et al._**MetaDome: Pathogenicity analysis of genetic variants through aggregation of homologous human protein domains.**[_Human Mutation, May 2019._](https://doi.org/10.1002/humu.23798)
@@ -25,18 +26,18 @@ Some of my work has been featured in the media, see [here](/media).
25
26
---
26
27
## 2025
27
28
28
-
1. I.B. Cooperstein, _et al._**An optimized variant prioritization process for rare disease diagnostics: recommendations for Exomiser and Genomiser.**[_Genome Medicine, October 2025_](https://doi.org/10.1186/s13073-025-01546-1)
29
-
2. M.T Arriaga, _et al._**Transcriptome-wide outlier approach identifies individuals with minor spliceopathies.**[_American Journal of Human Genetics, September 2025_](https://doi.org/10.1016/j.ajhg.2025.08.018)
30
-
3. S.N. Kobren, _et al._**Joint, multifaceted genomic analysis enables diagnosis of diverse, ultra-rare monogenic presentations.**[_Nature Communications, August 2025_](https://doi.org/10.1038/s41467-025-61712-2)
31
-
4. Y. Yamamoto, _et al._**Scaled multidimensional assays of variant effect identify sequence-function relationships in hypertrophic cardiomyopathy.**[_bioRxiv preprint, May 2025_](https://doi.org/10.1101/2025.05.23.655878)
29
+
1. M. Dawood, B. Heavner, M.M. Wheeler, R.A. Ungar, J. LoTempio, **_L. Wiel_**, _et al._**GREGoR: Accelerating Genomics for Rare Diseases.**[_Nature, November 2025_](https://doi.org/10.1038/s41586-025-09613-8)
30
+
2. I.B. Cooperstein, _et al._**An optimized variant prioritization process for rare disease diagnostics: recommendations for Exomiser and Genomiser.**[_Genome Medicine, October 2025_](https://doi.org/10.1186/s13073-025-01546-1)
31
+
3. M.T Arriaga, _et al._**Transcriptome-wide outlier approach identifies individuals with minor spliceopathies.**[_American Journal of Human Genetics, September 2025_](https://doi.org/10.1016/j.ajhg.2025.08.018)
32
+
4. S.N. Kobren, _et al._**Joint, multifaceted genomic analysis enables diagnosis of diverse, ultra-rare monogenic presentations.**[_Nature Communications, August 2025_](https://doi.org/10.1038/s41467-025-61712-2)
33
+
5. Y. Yamamoto, _et al._**Scaled multidimensional assays of variant effect identify sequence-function relationships in hypertrophic cardiomyopathy.**[_bioRxiv preprint, May 2025_](https://doi.org/10.1101/2025.05.23.655878)
32
34
33
35
---
34
36
## 2024
35
37
36
-
1. M. Dawood, _et al._**GREGoR: Accelerating Genomics for Rare Diseases.**[_arXiv preprint, December 2024_](https://arxiv.org/abs/2412.14338)
37
-
2. J.X. Chong, _et al._**Considerations for reporting variants in novel candidate genes identified during clinical genomic testing.**[_Genetics in Medicine, October 2024._](https://doi.org/10.1016/j.gim.2024.101199)
38
-
3. V.D. Nair, _et al._**Molecular adaptations in response to exercise training are associated with tissue-specific transcriptomic and epigenomic signatures.**[_Cell Genomics, May 2024._](https://doi.org/10.1016/j.xgen.2023.100421)
39
-
4. D. Amar, _et al._**The mitochondrial multi-omic response to exercise training across rat tissues.**[_Cell Metabolism, May 2024._](https://doi.org/10.1016/j.cmet.2023.12.021)
38
+
1. J.X. Chong, _et al._**Considerations for reporting variants in novel candidate genes identified during clinical genomic testing.**[_Genetics in Medicine, October 2024._](https://doi.org/10.1016/j.gim.2024.101199)
39
+
2. V.D. Nair, _et al._**Molecular adaptations in response to exercise training are associated with tissue-specific transcriptomic and epigenomic signatures.**[_Cell Genomics, May 2024._](https://doi.org/10.1016/j.xgen.2023.100421)
40
+
3. D. Amar, _et al._**The mitochondrial multi-omic response to exercise training across rat tissues.**[_Cell Metabolism, May 2024._](https://doi.org/10.1016/j.cmet.2023.12.021)
0 commit comments